Key publication
898
Therapeutic Areas
Methods & challenges

Key publication

Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave.

Key publication

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease.

Key publication

Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations.

Key publication

A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine.

1 July 2022

Movement disorders : official journal of the Movement Disorder Society

Read Publication

Key publication

Highlighting the Undetectable - Fluorescence Molecular Imaging in Gastrointestinal Endoscopy.

Key publication

Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.

Key publication

Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients.

Key publication

Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (Al)Al microtracer approach: a follow-up study in humans.

Key publication

Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease.